RE:OH RevenueCan't really disagree with anything you've said here. Market was expecting Q4 of 25 mil and we won't be anywhere near that. More concerning to me was the dismal margins reported in Q3 , hopefully that was a one time occurance.
On the bright side the revenue growth in Q4 will still be extremely strong, a double from 6.6 million seems within reach. We will just have a little longer revenue ramp up than expected, new dispensaries will be coming online at an increased rate and Floracal expansion should start to show up soon on the books.
We can also expect news on entering other markets like Nevada and Massachusetts. Strong cash postion and low share count gives them lots of options. Will be an exciting next few months.
ORHOF Origin House Revenue
First to be upfront, Origin House is my largest position.I'm concerned that the CEO Marc Lustig is another dreamer/talker/salesman. Q1 he said "But it’s certainly a corporate objective of ours to leave 2018 on a $100 million exit rate" Q2 he said " I am probably even more so confident about the statement that I made on Q1. I don't think it was unclear from our narrative today our confidence level going into the second half. We also dropped a couple of bread crumbs out there on the release regarding River and FloraCal for July.
And so as you start to put those numbers together for Q3 and then you make some assumptions about just continued expansion of the business in California maybe as Afzal mentioned a couple of branded product related acquisitions yes, I'd be super comfortable in backing up what I stated earlier." Q3 Cc transcript suddenly changed to "that was a aspirational goal" which per Dictionary.com "strong desire for something" Well entire Q3 revenue was 6.6 million. He is very, very far off 100 million exit rate for Q4.....which would be 25 million. I hope I'm wrong about him.But he stalled and stuttered with the answer. Wish he had been honest and admit he was overly optimistic.[/quote]